Vistari Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 M
as on 11-07-2024
- Revenue -37.87%
(FY 2018)
- Profit -134.78%
(FY 2018)
- Ebitda -104.79%
(FY 2018)
- Net Worth -7.71%
(FY 2018)
- Total Assets -74.14%
(FY 2018)
About Vistari Biotech
The Corporate was formerly known as Vista Solar Power Private Limited. The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Priyanka Bharti and Nitish Kumar serve as directors at the Company.
- CIN/LLPIN
U01100DL2011PTC220239
- Company No.
220239
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vistari Biotech Private Limited offer?
Vistari Biotech Private Limited offers a wide range of products and services, including Solar Lamps, Solar Lantern, Boundary Fencing, Safety Fence, Solar Home Light, Solar Home Light Systems, Solar Pumps, Industrial Heaters, Industrial Water Heating System, Street Lights.
Who are the key members and board of directors at Vistari Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Bharti  | Director | 19-May-2020 | Current |
| Nitish Kumar | Director | 30-Nov-2018 | Current |
Financial Performance of Vistari Biotech.
Vistari Biotech Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 37.87% decrease. The company also saw a substantial fall in profitability, with a 134.78% decrease in profit. The company's net worth dipped by a decrease of 7.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vistari Biotech?
In 2018, Vistari Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Janalakshmi Financial Services Private Limited Creation Date: 31 Jan 2015 | ₹1.50 M | Satisfied |
How Many Employees Work at Vistari Biotech?
Unlock and access historical data on people associated with Vistari Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vistari Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vistari Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
